Literature DB >> 1779650

Familial combined hyperlipidaemia: use of stable isotopes to demonstrate overproduction of very low-density lipoprotein apolipoprotein B by the liver.

J A Cortner1, P M Coates, M J Bennett, D R Cryer, N A Le.   

Abstract

We have assessed very low-density lipoprotein apolipoprotein B production, using [15N]glycine as an endogenous marker in a 9-hour primed constant infusion protocol, in four adult male subjects with familial combined hyperlipidaemia and in four normolipidaemic adult male controls. The mean very low-density lipoprotein apolipoprotein B absolute synthetic rate was significantly greater in the familial combined hyperlipidaemic subjects than in control subjects (26.31 +/- 8.37 vs 9.36 +/- 4.07 mg/kg per 24 h, p less than 0.05). These results confirm findings using exogenous radioisotope labelling techniques that very low-density lipoprotein apolipoprotein B production is significantly increased in most patients with familial combined hyperlipidaemia. A modified 9-hour protocol can be safely done repeatedly and in children and pregnant women.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1779650     DOI: 10.1007/bf01800473

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  16 in total

1.  Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding.

Authors:  J S Cohn; D A Wagner; S D Cohn; J S Millar; E J Schaefer
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

2.  Prevalence and expression of familial combined hyperlipidemia in childhood.

Authors:  J A Cortner; P M Coates; P R Gallagher
Journal:  J Pediatr       Date:  1990-04       Impact factor: 4.406

3.  Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype.

Authors:  H G Rose; P Kranz; M Weinstock; J Juliano; J I Haft
Journal:  Am J Med       Date:  1973-02       Impact factor: 4.965

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia.

Authors:  A Chait; J J Albers; J D Brunzell
Journal:  Eur J Clin Invest       Date:  1980-02       Impact factor: 4.686

6.  Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction.

Authors:  J L Goldstein; W R Hazzard; H G Schrott; E L Bierman; A G Motulsky
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

7.  Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.

Authors:  J L Goldstein; H G Schrott; W R Hazzard; E L Bierman; A G Motulsky
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

8.  Direct measurement of apolipoprotein B synthesis in human very low density lipoprotein using stable isotopes and mass spectrometry.

Authors:  D R Cryer; T Matsushima; J B Marsh; M Yudkoff; P M Coates; J A Cortner
Journal:  J Lipid Res       Date:  1986-05       Impact factor: 5.922

9.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

10.  Measurement of apolipoprotein B synthesis in perfused rat liver using stable isotopes: [15N]hippurate as a measure of the intracellular [15N]glycine precursor enrichment.

Authors:  T Matsushima; D R Cryer; K E Winkler; J B Marsh; J A Cortner
Journal:  J Lipid Res       Date:  1989-06       Impact factor: 5.922

View more
  7 in total

Review 1.  Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

Authors:  R A Hegele
Journal:  Am J Hum Genet       Date:  2001-10-26       Impact factor: 11.025

2.  The effect of lovastatin on very low-density lipoprotein apolipoprotein B production by the liver in familial combined hyperlipidaemia.

Authors:  J A Cortner; M J Bennett; N A Le; P M Coates
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

3.  Fish oil -- how does it reduce plasma triglycerides?

Authors:  Gregory C Shearer; Olga V Savinova; William S Harris
Journal:  Biochim Biophys Acta       Date:  2011-10-25

4.  Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.

Authors:  G M Dallinga-Thie; M van Linde-Sibenius Trip; J I Rotter; R M Cantor; X Bu; A J Lusis; T W de Bruin
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

5.  A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.

Authors:  B E Aouizerat; H Allayee; R M Cantor; R C Davis; C D Lanning; P Z Wen; G M Dallinga-Thie; T W de Bruin; J I Rotter; A J Lusis
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

6.  Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.

Authors:  M Castro Cabezas; T W de Bruin; H W de Valk; C C Shoulders; H Jansen; D Willem Erkelens
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

7.  Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype.

Authors:  H Allayee; B E Aouizerat; R M Cantor; G M Dallinga-Thie; R M Krauss; C D Lanning; J I Rotter; A J Lusis; T W de Bruin
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.